Technical Analysis for LIFE - aTyr Pharma, Inc

Grade Last Price % Change Price Change
grade B 3.03 -1.30% -0.0400
LIFE closed down 1.3 percent on Monday, September 9, 2019, on 6 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A N/A Up
See historical LIFE trend table...

Date Alert Name Type % Chg
Inside Day Range Contraction 0.00%
New 52 Week Closing High Bullish -1.30%
Spinning Top Other -1.30%
New 52 Week High Strength -1.30%
Gapped Up Strength -1.30%
Outside Day Range Expansion 441.46%
NR7 Range Contraction 466.99%
Bullish Engulfing Bullish 449.91%
New 52 Week Low Weakness 449.91%
Outside Day Range Expansion 449.91%

Older signals for LIFE ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
aTyr Pharma, Inc., a clinical stage biotechnology company, engages in the discovery and development of medicines for the treatment of cancer and lung disease in the United States. The company's therapeutic candidate pipeline that includes ATYR1923 candidate, an agonist of the Resokine pathway that is in Phase I clinical trial designed to temper immune engagement in interstitial lung diseases; and ORCA program, a preclinical research stage program that targets immuno-oncology pathway using antibodies to enhance the immune response in tumor settings. It is also developing ATYR1940, a therapeutic candidate based on a protein naturally secreted from muscle for the treatment of facioscapulohumeral muscular dystrophy, limb-girdle muscular dystrophy, and duchenne muscular dystrophy. aTyr Pharma, Inc. has collaboration with the University of Nebraska Medical Center to advance neuropilin-2 biology and therapeutic opportunities for ATYR1923. The company was founded in 2005 and is headquartered in San Diego, California.
Medicine Biotechnology RTT Medical Specialties Cancer Organ Systems Treatment Of Cancer Antibodies Tumor Cancer Immunotherapy Stage Biotechnology Muscular Dystrophy Duchenne Muscular Dystrophy Duchenne Dystrophy
Is LIFE a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 0 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 3.15
52 Week Low 0.4852
Average Volume 184,300
200-Day Moving Average 0.0
50-Day Moving Average 0.0
20-Day Moving Average 0.0
10-Day Moving Average 1.1112
Average True Range 0.0
ADX 0.0
+DI 0.0
-DI 0.0
Chandelier Exit (Long, 3 ATRs ) N/A
Chandelier Exit (Short, 3 ATRs ) N/A
Upper Bollinger Band 0.0
Lower Bollinger Band 0.0
Percent B (%b) 0.0
BandWidth 0.0
MACD Line 0.1527
MACD Signal Line 0.0305
MACD Histogram 0.1222
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.1430
Resistance 3 (R3) 3.1522 3.1238 3.1241
Resistance 2 (R2) 3.1238 3.0950 3.1192 3.1178
Resistance 1 (R1) 3.0769 3.0773 3.0627 3.0677 3.1116
Pivot Point 3.0485 3.0485 3.0414 3.0439 3.0485
Support 1 (S1) 3.0016 3.0197 2.9874 2.9924 2.9484
Support 2 (S2) 2.9732 3.0020 2.9686 2.9422
Support 3 (S3) 2.9263 2.9732 2.9359
Support 4 (S4) 2.9171